Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Ph 2 Outlook positive
View:
Post by Kingpin68 on Dec 02, 2021 2:19pm

Ph 2 Outlook positive

One difference in this quarters newsletter, besides the improved numbers and trend, was Dr. Madzarevic's positive messaging with the trend in results. Albeit with the necessary disclaimers. Great things ahead of us.
Comment by Oilminerdeluxe on Dec 02, 2021 2:28pm
Not that I know how close they are but if they were to announce that 'Oh, by the way, we will start GBM trials in March'... Would go nuts in value appreciation. A guy can dream right?
Comment by robertshaw on Dec 02, 2021 2:45pm
now I only dream of get Blowjobjoe's bosses an epic short squeeze to 0.78.
Comment by Oilminerdeluxe on Dec 02, 2021 2:50pm
RobertShaw, that would be nice indeed.
Comment by robertshaw on Dec 02, 2021 3:17pm
About 2 months ago, after I loaded 120k @0.205,and Blowjobjoe's bosses naked shorted even more shares to as low as 0.18 thereafter even when they saw RDW and Kristina also bought at 0.20, I know Blowjobjoe's bosses are all nuts and totally clueless....
Comment by CancerSlayer on Dec 03, 2021 1:05am
  And much of the market has yet to catch on or take a bite...not only do existing data & data trends need additional digesting, many simply need a more substantive/digestible "news flash moment" (i.e. a BTD).  Nonetheless, I'm still expecting less volatility & an overall upward trend in sp until the next news release. Looking at our "currently evaluable ...more  
Comment by Oilminerdeluxe on Dec 03, 2021 5:09am
Would not mind it if the volume continues today
Comment by Oden6570 on Dec 03, 2021 5:36am
FOMO is highly contagious:-)
Comment by Oilminerdeluxe on Dec 03, 2021 5:44am
I have a good friend who owns 10 x what I do. He is very happy today. Finally in the green. He reads this board like mad every day but is not registered to post.. He will probably have a question or two for the board this weekend via me. I think it will be about GBM or lung or something. Hope the strength remains
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250